Location · Providence, RI
Clinical trials in Providence, RI
97 recruiting studies have a site in Providence, and 52 of them accept healthy volunteers.
97 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 2
A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D)
Eli Lilly and Company
- Location
- Providence, RI + 13 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Constipation (IBS-C)
Eli Lilly and Company
- Location
- Providence, RI + 13 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Eli Lilly and Company
- Location
- Providence, RI + 36 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 3
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Eli Lilly and Company
- Location
- Providence, RI + 34 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 2
A Study of Brenipatide in Participants With Opioid Use Disorder
Eli Lilly and Company
- Location
- Providence, RI + 35 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Spyre Therapeutics, Inc.
- Location
- Providence, RI + 25 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Hoffmann-La Roche
- Location
- Providence, RI + 58 other US sites
- Eligibility basics
- Ages 16–80
- RecruitingPhase 2
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
Takeda
- Location
- Providence, RI + 23 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
Comparing The Safety And Efficacy Of DEFENCATH® In Reducing Central-Line Bloodstream Infections (CLABSIs) In Adults And Adolescent Participants Receiving Total Parenteral Nutrition Through A Central Venous Catheter (CVC)
CorMedix Therapeutics
- Location
- Providence, RI + 16 other US sites
- Eligibility basics
- Ages 12+
- RecruitingPhase 2/Phase 3
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Janssen Research & Development, LLC
- Location
- Providence, RI + 53 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Janssen Research & Development, LLC
- Location
- Providence, RI + 50 other US sites
- Eligibility basics
- Ages 12+
- RecruitingPhase 2
Study of DISC-0974-201 in Participants With IBD and Anemia
Disc Medicine, Inc
- Location
- Providence, RI + 14 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Location
- Providence, RI + 43 other US sites
- Eligibility basics
- Ages 55–90
- RecruitingPhase 4
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Takeda
- Location
- Providence, RI + 36 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 3
A Study of Suvorexant (MK-4305) for the Treatment of Insomnia Disorder in Participants With Opioid Use Disorder (MK-4305-098)
Merck Sharp & Dohme LLC
- Location
- Providence, RI + 12 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 1/Phase 2
A Study of HS235 for Treatment of Pulmonary Arterial Hypertension (PAH) in Adults
35Pharma Inc
- Location
- Providence, RI + 1 other US site
- Eligibility basics
- Ages 18+
- Recruiting
DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis
Inari Medical
- Location
- Providence, RI + 32 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
Pulmovant, Inc.
- Location
- Providence, RI + 12 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingPhase 2
Study of DONQ52 in Active Celiac Disease
Chugai Pharmaceutical
- Location
- Providence, RI + 57 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
BlueRock Therapeutics
- Location
- Providence, RI + 33 other US sites
- Eligibility basics
- Ages 45–75
- Recruiting
The THOR IDE Study
Philips Clinical & Medical Affairs Global
- Location
- Providence, RI + 28 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Self Neuro-modulation Therapy for Major Depressive Disorder (MDD) With Anhedonia
GrayMatters Health Ltd.
- Location
- Providence, RI + 1 other US site
- Eligibility basics
- Ages 22–75
- Recruiting
SELUTION4BTK Trial
M.A. Med Alliance S.A.
- Location
- Providence, RI + 24 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Mirador Therapeutics, Inc.
- Location
- Providence, RI + 42 other US sites
- Eligibility basics
- Ages 18–80